BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2303309)

  • 1. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicardipine treatment of hypertension during pregnancy.
    Carbonne B; Jannet D; Touboul C; Khelifati Y; Milliez J
    Obstet Gynecol; 1993 Jun; 81(6):908-14. PubMed ID: 8497354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicardipine: an effective new agent for the treatment of severe hypertension.
    Clifton GG; Wallin JD
    Angiology; 1990 Nov; 41(11 Pt 2):1005-9. PubMed ID: 2248422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous nicardipine for treatment of severe hypertension in children.
    Flynn JT; Mottes TA; Brophy PD; Kershaw DB; Smoyer WE; Bunchman TE
    J Pediatr; 2001 Jul; 139(1):38-43. PubMed ID: 11445792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of nicardipine in 29,104 patients with hypertension.
    Dubois C; Blanchard D
    Clin Ther; 1989; 11(4):452-60. PubMed ID: 2673515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effects of intravenous nicardipine in arterial hypertension in the elderly].
    Escande M; David D; Diadema B
    Therapie; 1989; 44(3):161-5. PubMed ID: 2675376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute titration and chronic follow-up with captopril in hypertension. A one-year safety profile on combination therapy with captopril and a diuretic.
    Mahapatra D; Mahapatra RK; Yaden S; Hunter KW
    Angiology; 1986 Dec; 37(12 Pt 1):865-79. PubMed ID: 2880534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of nicardipine retard and captopril in hypertension in the aged. Results of a multicenter study].
    Mancia G; Buoninconti R; Errico M; Freda M; Giordano MP; Granata Q; Lucentini ML; Marsili P; Pasotti C; Piccolo E
    Minerva Med; 1992 Nov; 83(11):731-8. PubMed ID: 1461544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial.
    Wallin JD; Fletcher E; Ram CV; Cook ME; Cheung DG; MacCarthy EP; Townsend R; Saunders E; Davis WR; Langford HG
    Arch Intern Med; 1989 Dec; 149(12):2662-9. PubMed ID: 2688586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
    Palermo R; Conti V; Agostinelli MC; Ganzetti S; Racco F; Melappioni A; Pratillo G; Moretti S
    Clin Ther; 1990; 12(2):149-56. PubMed ID: 2354484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive effect and tolerability of slow-release nicardipine].
    Fogari R; Poletti L; Tettamanti F; Malamani G; Borgnino C
    Cardiologia; 1989 Feb; 34(2):161-5. PubMed ID: 2660993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
    Malesker MA; Hilleman DE
    J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.